Virpax Pharmaceuticals 株価情報 (NASDAQ: VRPX)

最新ニュース Virpax Pharmaceuticals (NASDAQ:VRPX) 株価情報

Virpax Pharmaceuticals

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Five,Below,Now,Open,-,Closeup,Of,Sign,On,Building

AGMH

AKBA

BHIL

DEVS

EFXT

FIVE

IOBT

MAZE

MHUA

OPTN

RVSB

VRPX

ZCAR

米国の小売業者ファイブ・ビロウ(Five Below）の株は、市場予想を上回る四半期決算を発表し、第1四半期の見通し予想を上回ることを受け、市場取引開始前の取引で株価が急上昇した。

なぜ、ファイブ・ビロウの株価が12%上昇しているのか；プレマーケットで変動している20銘柄

Virpax Pharmaceuticals, Inc. - Common Stock

Virpax Pharmaceuticals Inc

On Friday, Benchmark analyst Josh Sullivan reiterated the Buy rating on Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>), <a target="_blank" href="https://www.benzinga.com/quote/PL/analyst-ratings" rel="noreferrer noopener">with a price forecast of $7.</a>
Yesterday, the company reported fourth-quarter adjusted losses of 8 cents per share,&nbsp;<a target="_blank" href="https://www.benzinga.com/25/03/44434960/planet-labs-shares-drop-after-q4-miss-below-consensus-q1-fy26-guidance" rel="noreferrer noopener">missing the consensus of 2 cents</a>. Revenue of&nbsp;$61.6&nbsp;million, up 5% year over year, missed&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">the consensus of $61.87 million</a>.
Planet Labs expects&nbsp;revenue in a range of&nbsp;$61 million&nbsp;to&nbsp;$63 million for first-quarter FY26 and $260 million to $280 million for FY26.
The analyst highlights that the $230 million commercial agreement with JSAT, signed late last year, marked a pivotal shift for Planet Labs.
This strategic decision to sell JSAT satellite hardware directly, rather than relying on traditional data feeds from Planet Labs-owned satellites, is expected to significantly reduce PL&#8217;s cash burn by 50% in FY26, with a clear path toward positive free cash flow within the next two years.
Also Read:<a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/03/44439892/whats-going-on-with-redwire-corporation-stock-today" rel="noreferrer noopener"> What&#8217;s Going On With Redwire Corporation Stock Today?</a>
Once the JSAT constellation is fully deployed, Planet Labs will have the opportunity to sell data feeds to third-party customers, further boosting its margins, the analyst writes.
Sullivan further notes that the transition in FY25 toward solution-based products sets the stage for FY26, when Planet Labs plans to focus on leveraging its extensive satellite data library and AI products.
Additionally, Planet Labs anticipates strong growth in the commercial agricultural market as it enters FY26, with recent customer wins, renewals, and an increase in data usage from larger agricultural companies.
Price Action: PL shares are trading lower by 12.5% to $3.71 at last check Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44431990/us-stocks-likely-to-open-lower-economic-conditions-dont-signal-a-downturn-say-analysts-as-they-expect-resilient-earnings-to-lift-equities" target="_blank" rel="noreferrer noopener">US Stocks Likely To Open Lower, But ‘Economic Conditions Don&#8217;t Signal A Downturn,&#8217; Say Analysts As They Expect ‘Resilient Earnings&#8217; To Lift Equities</a></li>
</ul>
Photo by rafapress via Shutterstock.

Analyst Color

Equities

News

Price Target

Reiteration

Markets

Analyst Ratings

Movers

Trading Ideas

General

Planet Labs' Pivot To Solutions And AI Signals Long-Term Upside, Says Analyst

Canaccord Genuity analyst Luke Hannan maintains BRP (TSX:<a class="ticker" href="https://www.benzinga.com/stock/DOO#TSX">DOO</a>) with a Hold and lowers the price target from C$80 to C$60.

DOOO

TSX:DOO

Canaccord Genuity Maintains Hold on BRP, Lowers Price Target to C$60

WIIM

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

MicroCloud Hologram shares are trading higher after the company reported a year-over-year increase in FY24 EPS and revenue results.

CORRECTION: MicroCloud Hologram reported a year-over-year increase in FY24 financial results.

Canaccord Genuity analyst Caitlin Cronin maintains TELA Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELA#NASDAQ">TELA</a>) with a Buy and lowers the price target from $12 to $7.

TELA

Canaccord Genuity Maintains Buy on TELA Bio, Lowers Price Target to $7

Canaccord Genuity analyst Whitney Ijem maintains Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and raises the price target from $385 to $390.

ALNY

Canaccord Genuity Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $390

Streaming giant Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) is launching a new reality competition set in the familiar world of Willy Wonka. The company continues to bet on reality series to attract new subscribers and keep its large base <a href="https://www.benzinga.com/general/entertainment/24/06/39213738/netflix-reality-show-games-and-chill-streaming-giant-sees-success-from-interactive-games-ba">of existing subscribers.</a>
What Happened: In a move that could follow the success Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) had with "Beast Games"<a href="https://www.benzinga.com/general/entertainment/24/12/42657482/mrbeast-dominates-prime-video-how-youtuber-could-help-amazon-boost-streaming-presence"> from content creator</a> MrBeast, Netflix is launching a reality competition in the spirit of the literary classic "Charlie and the Chocolate Factory."
Netflix is currently <a href="https://us.castitreach.com/ag/realcasting/thegoldenticketcasting/welcome.html">casting </a>U.S. residents aged 18 or older in a competition called "Wonka: The Golden Ticket."
"For the first time ever, the doors of Wonka's Chocolate Factory are opening for you," Netflix <a href="https://www.netflix.com/tudum/articles/the-golden-ticket-season-1-release-date-news">said </a>in an announcement.
The series says people are "invited to a competition beyond imagination" as the signature "Pure Imagination" song from the Willy Wonka movies plays in the trailer's background.
Netflix said players who get the "golden ticket" to be in the competition will have to adapt and strategize in the "high-stakes social experiment" as their ticket will take them only so far.
Players will compete in games, tests and temptations throughout the series. The series announcement promises a huge prize for the winner of the series, which will take place in an immersive factory.
Netflix said a premiere date for the reality competition will be announced later.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/01/43114866/netflix-q4-earnings-record-subscribers-nfl-squid-game-push-past-highest-expectations">Netflix Q4 Earnings: Record Subscribers, NFL, &#8216;Squid Game&#8217; Push Past &#8216;Highest Expectations&#8217;</a>
Why It's Important: Netflix continues to add more original content to its streaming library, which includes added efforts for live sports and reality competitions in recent years.
"We are thrilled to bring the magic of The Chocolate Factory to life like never before," Netflix Vice President of Unscripted Jeff Gaspin said. "This one-of-a-kind reality competition blends adventure, strategy, and social dynamics, creating an experience that is as captivating as it is unpredictable."
Gaspin said the lucky few participants in the competition "won't just have to imagine the experience – they'll get to step inside the factory."
The reality series could attempt to mirror the success of Beast Games, which saw MrBeast offer huge prizes for contestants in competitions, group decisions, and more social experiments. MrBeast previously released a Willy Wonka-themed video that featured competitions and has over 335 million views on YouTube.
Willy Wonka comes with huge brand recognition thanks to several big screen movie adaptations of the literary character including the recent 2023 Warner Bros. Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) motion picture "Wonka," which starred Timothee Chalamet in the title role.
"Wonka" grossed $218.4 million domestically and $634.5 million worldwide.
Netflix acquired the Roald Dahl Story Company in 2021, one of its largest acquisitions to date. The acquisition gives the company additional rights to several books and IP based on Roald Dahl characters. Dahl is the author of "Charlie and the Chocolate Factory."
The streaming company has released "Matilda the Musical" and "The Wonderful World of Henry Sugar" in recent years, which are based off of Dahl characters. Netflix will also release the animated movie "The Twits" later this year, based on a 1980 book from Dahl.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/03/44428025/netflix-to-launch-first-mmo-video-game-is-it-the-streaming-companys-biggest-gaming-bet-yet">Netflix To Launch First MMO Video Game: Is It The Streaming Company&#8217;s Biggest Gaming Bet Yet?</a></li>
</ul>
Photo: Sandro Amato/Shutterstock.com

Entertainment

AMZN

NFLX

Netflix Announces Willy Wonka-Inspired Reality Competition With A 'Golden Ticket' Twist

Grant Cardone recently posted <a href="https://x.com/GrantCardone/status/1900247657680920980">on X</a>, "Don&#8217;t be surprised when President Trump eliminates the IRS."&nbsp;
The comment sparked a flood of reactions online and renewed attention to Cardone&#8217;s longstanding criticism of the Internal Revenue Service. Cardone, a real estate mogul and social media personality, has been vocal about his dislike for the IRS and his belief that Americans should not have to pay income taxes.
<h2 class="wp-block-heading">Cardone&#8217;s Criticism of the IRS</h2>
Cardone has never hidden his frustration with the IRS. In a recent <a href="https://www.youtube.com/watch?v=b28RkD2JEq4&amp;t=3s">interview</a> with independent reporter Nicholas Ballasy, Cardone doubled down on his stance, stating that he would never help or employ anyone from the IRS.
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
<li>This Startup Is On The Brink Of A Huge Disruption To The $654 Billion Industry – <a href="https://www.benzinga.com/money/venhub-adv">Invest In It Before It Fulfills 800 Pre-Orders</a></li>
</ul>
"There's an exception to who I will help. There's only one group exempted from that offer: the IRS. I will not offer you a job or help. The only thing I give you is this," Cardone said while raising his middle finger.
When Ballasy pressed Cardone on whether he believes the IRS is necessary, Cardone questioned the agency&#8217;s purpose. "Do you think you benefit from me paying taxes?" he asked. "I paid $12 million last year and $40 million in property taxes. Did you get any of that money?"
Cardone argued that tax withholding is essentially the government holding onto money that belongs to Americans. He estimated that if the government stopped withholding taxes, Americans could have earned an additional $81 billion in interest over the year.
Trending: Hasbro, MGM Resorts, and Sketchers Use this Pre-IO AI Marketing Firm — <a href="https://www.benzinga.com/money/rad-intel">and You Can Own a Piece of it From $0.55/Share</a>
<h2 class="wp-block-heading">Trump&#8217;s Proposal to Replace the IRS with Tariffs</h2>
Cardone's statement comes amid growing speculation about President Donald Trump's plans for the IRS. Trump has floated the idea of <a href="https://www.benzinga.com/markets/25/02/43840909/trumps-goal-is-to-abolish-irs-and-let-all-the-outsiders-pay-says-newly-confirmed-commerce-secretary-howard-lutnick">abolishing the IRS</a> and replacing income taxes with revenue from tariffs. Commerce Secretary <a href="https://www.benzinga.com/markets/25/03/44295365/trump-wants-no-tax-for-americans-making-less-than-150000-a-year-says-howard-lutnick-thats-what-im-working-for">Howard Lutnick</a> recently told Fox News that Trump's goal is to "abolish the Internal Revenue Service and let all the outsiders pay."
The idea is that America could generate enough revenue from tariffs on imported goods to eliminate the need for income taxes. However, economic experts have raised concerns about the feasibility of this plan.
Torsten Slok, chief economist at Apollo Global Management, <a href="https://www.apolloacademy.com/challenging-to-replace-income-taxes-with-tariffs/">explains</a> that the U.S. collects about $3 trillion annually from income taxes. Since the U.S. imports around $3 trillion worth of goods each year, tariffs would need to be at least 100% on all imported goods to replace income tax revenue. But Slok said raising prices that high could reduce consumer demand, making it difficult to sustain revenue at that level.
"The challenge is that it is unclear what will happen to sales if all imported products double in price," Slok wrote on Apollo's website. "It may require tariffs as high as 200% on all imported goods for the total tariff revenue to replace income taxes."
See Also: This platform is reshaping how you invest in private companies —<a href="https://www.benzinga.com/money/kingscrowd-adv"> and you can be a part of it for $0.18 per share</a>
<h2 class="wp-block-heading">Legislative Moves to Abolish the IRS</h2>
Separately, House Republicans have introduced the Fair Tax Act of 2025, which seeks to dismantle the IRS and replace income and corporate taxes with a national sales tax. The <a href="https://www.congress.gov/bill/119th-congress/house-bill/25/all-info">proposal</a>, introduced by Rep. Earl L. "Buddy" Carter (R-GA), has gained traction with some conservatives who see tariffs and consumption taxes as a fairer alternative to income taxes.
While Trump's tariff-based revenue plan aligns with the goals of the Fair Tax Act, economists warn that the strategy could hurt economic growth. <a href="https://www.benzinga.com/news/25/03/44347512/wait-tariffs-are-just-a-tax-on-us-employee-shocked-as-small-business-owner-cuts-his-hours-because-of-the-tariffs">Higher tariffs</a> could lead to higher consumer prices and reduced demand for imported goods, potentially undercutting the expected revenue from tariffs.
<h2 class="wp-block-heading">What's Next?</h2>
Cardone's post reflects growing public interest in the future of the IRS and Trump's tax plans. However, replacing income taxes with tariffs would require significant adjustments to the U.S. economy and could face resistance from both lawmakers and consumers. Whether Trump will follow through with these plans remains uncertain — but for now, the IRS is still very much in place.
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Personal Finance

Grant Cardone Says 'Don't Be Surprised When President Trump Eliminates The IRS'

Canaccord Genuity analyst Kingsley Crane maintains Alarum Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) with a Buy and lowers the price target from $25 to $11.

ALAR

Canaccord Genuity Maintains Buy on Alarum Technologies, Lowers Price Target to $11

Financial giants have made a conspicuous bearish move on ON Semiconductor. Our analysis of options history for ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) revealed 17 unusual trades.
Delving into the details, we found 11% of traders were bullish, while 82% showed bearish tendencies. Out of all the trades we spotted, 14 were puts, with a value of $1,380,883, and 3 were calls, valued at $175,726.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $50.0 to $75.0 for ON Semiconductor over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in ON Semiconductor's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to ON Semiconductor's substantial trades, within a strike price spectrum from $50.0 to $75.0 over the preceding 30 days.
<h3>ON Semiconductor Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742577441_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$12.6</td>
<td>$12.5</td>
<td>$12.57</td>
<td>$50.00</td>
<td>$339.2K</td>
<td align="right">0</td>
<td align="right">612</td>
</tr>
<tr>
<td>ON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/18/26</td>
<td>$12.55</td>
<td>$12.5</td>
<td>$12.55</td>
<td>$50.00</td>
<td>$199.4K</td>
<td align="right">0</td>
<td align="right">302</td>
</tr>
<tr>
<td>ON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$12.55</td>
<td>$12.45</td>
<td>$12.53</td>
<td>$50.00</td>
<td>$163.0K</td>
<td align="right">0</td>
<td align="right">130</td>
</tr>
<tr>
<td>ON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$12.55</td>
<td>$12.5</td>
<td>$12.53</td>
<td>$50.00</td>
<td>$145.4K</td>
<td align="right">0</td>
<td align="right">768</td>
</tr>
<tr>
<td>ON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$12.6</td>
<td>$11.55</td>
<td>$12.53</td>
<td>$50.00</td>
<td>$116.6K</td>
<td align="right">0</td>
<td align="right">951</td>
</tr>
</tbody>
</table>

<h3>About ON Semiconductor</h3>
Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.
After a thorough review of the options trading surrounding ON Semiconductor, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of ON Semiconductor</h3>
<ul>
<li>Trading volume stands at 3,610,104, with ON's price down by -2.13%, positioned at $42.28.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 38 days.</li>
</ul>
<h3>Expert Opinions on ON Semiconductor</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $53.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $57. 
&#x2A; Maintaining their stance, an analyst from Rosenblatt continues to hold a Neutral rating for ON Semiconductor, targeting a price of $49. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for ON Semiconductor, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

ON Semiconductor Options Trading: A Deep Dive into Market Sentiment

Investors with a lot of money to spend have taken a bearish stance on Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with VKTX, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Viking Therapeutics.
This isn't normal.
The overall sentiment of these big-money traders is split between 37% bullish and 62%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $315,085, and 2 are calls, for a total amount of $67,318.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $25.0 to $32.5 for Viking Therapeutics over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Viking Therapeutics's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Viking Therapeutics's whale trades within a strike price range from $25.0 to $32.5 in the last 30 days. 
<h3>Viking Therapeutics Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742577436_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VKTX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$4.85</td>
<td>$4.75</td>
<td>$4.75</td>
<td>$30.00</td>
<td>$100.2K</td>
<td>3.2K</td>
<td>262</td>
</tr>
<tr>
<td>VKTX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$2.02</td>
<td>$1.71</td>
<td>$2.02</td>
<td>$30.00</td>
<td>$60.6K</td>
<td>2.8K</td>
<td>966</td>
</tr>
<tr>
<td>VKTX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.78</td>
<td>$1.35</td>
<td>$1.78</td>
<td>$30.00</td>
<td>$48.9K</td>
<td>2.8K</td>
<td>1.3K</td>
</tr>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.48</td>
<td>$1.4</td>
<td>$1.44</td>
<td>$32.50</td>
<td>$40.9K</td>
<td>3.7K</td>
<td>66</td>
</tr>
<tr>
<td>VKTX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$2.06</td>
<td>$1.57</td>
<td>$1.88</td>
<td>$30.00</td>
<td>$37.6K</td>
<td>2.8K</td>
<td>366</td>
</tr>
</tbody>
</table>

<h3>About Viking Therapeutics</h3>
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Having examined the options trading patterns of Viking Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Viking Therapeutics Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,145,610, the VKTX's price is down by -1.23%, now at $28.0. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 33 days.</li>
</ul>
<h3>Professional Analyst Ratings for Viking Therapeutics</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $102.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from HC Wainwright &amp; Co. downgraded its rating to Buy, setting a price target of $102. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Viking Therapeutics options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

VKTX

Market Whales and Their Recent Bets on VKTX Options

Deep-pocketed investors have adopted a bullish approach towards Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in TTWO usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 15 extraordinary options activities for Take-Two Interactive. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 46% leaning bullish and 46% bearish. Among these notable options, 10 are puts, totaling $896,803, and 5 are calls, amounting to $302,056.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $200.0 and $240.0 for Take-Two Interactive, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Take-Two Interactive's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Take-Two Interactive's whale activity within a strike price range from $200.0 to $240.0 in the last 30 days. 
<h3>Take-Two Interactive 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742577430_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TTWO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$12.5</td>
<td>$11.6</td>
<td>$12.5</td>
<td>$200.00</td>
<td>$216.2K</td>
<td>20</td>
<td>513</td>
</tr>
<tr>
<td>TTWO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$12.5</td>
<td>$11.6</td>
<td>$12.5</td>
<td>$200.00</td>
<td>$143.7K</td>
<td>20</td>
<td>229</td>
</tr>
<tr>
<td>TTWO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$15.15</td>
<td>$14.8</td>
<td>$15.05</td>
<td>$210.00</td>
<td>$108.3K</td>
<td>1.2K</td>
<td>82</td>
</tr>
<tr>
<td>TTWO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$12.6</td>
<td>$11.7</td>
<td>$12.5</td>
<td>$200.00</td>
<td>$90.0K</td>
<td>20</td>
<td>868</td>
</tr>
<tr>
<td>TTWO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$12.45</td>
<td>$11.6</td>
<td>$12.25</td>
<td>$200.00</td>
<td>$83.3K</td>
<td>20</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About Take-Two Interactive</h3>
Take-Two is one of the largest global developers and publishers of video games, with labels including Rockstar, 2K, and Zynga. Grand Theft Auto is the firm's biggest franchise, accounting for about 30% of total sales for the past decade. NBA 2K is the industry's dominant basketball video game, with Take-Two releasing a new version annually. Other notable franchises include Red Dead Redemption, Borderlands, and Civilization. Typically, more than three quarters of the firm's sales are from in-game spending, with the remainder coming from initial game sales. Since acquiring Zynga in 2022, mobile makes up about half of total sales.
In light of the recent options history for Take-Two Interactive, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Take-Two Interactive's Current Market Status</h3>
<ul>
<li>Trading volume stands at 1,045,309, with TTWO's price down by -1.14%, positioned at $207.24.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 55 days.</li>
</ul>
<h3>Professional Analyst Ratings for Take-Two Interactive</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $270.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Ascendiant Capital continues to hold a Buy rating for Take-Two Interactive, targeting a price of $270. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Take-Two Interactive, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

TTWO

Smart Money Is Betting Big In TTWO Options

Boeing Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) shares are trading higher Friday after the company secured a major U.S. Air Force contract for the Next Generation Air <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44438628/president-trump-awards-boeing-next-generation-fighter-jet-contract-worth-at-least">Dominance fighter jet</a><a href="https://www.benzinga.com/markets/25/03/44411079/boeing-frustrations-reach-crescendo-at-airline-founded-by-warren-buffett-of-india-we-just-dont-have-enough-aircraft-to-fly">. </a>
What To Know: According to Reuters, President Donald Trump awarded Boeing the contract for the Next Generation Air Dominance (NGAD) program, which will replace Lockheed Martin's F-22 Raptor with a new crewed aircraft designed to operate alongside drones.
The contract is worth over $20 billion for the engineering and manufacturing phase, with total orders expected to reach hundreds of billions over its lifetime. The NGAD fighter's design details remain classified but will likely include stealth capabilities, advanced sensors, and high-performance engines.
This contract is a major win for Boeing after years of struggles in both its commercial and defense divisions. The company has faced production and safety issues in its commercial aircraft business, as well as challenges securing new defense contracts. The NGAD deal provides a major boost to Boeing's fighter jet production operations in St. Louis, Missouri, securing work for the facility for years to come.
BA Price Action: Boeing shares were up 5.40% at $182.22 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga pro</a>.
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="533" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21121820/Screenshot-2025-03-21-at-12.17.58-1024x533.png" alt="" class="wp-image-836379" style="width:468px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21121820/Screenshot-2025-03-21-at-12.17.58-1024x533.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21121820/Screenshot-2025-03-21-at-12.17.58-300x156.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21121820/Screenshot-2025-03-21-at-12.17.58-768x400.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21121820/Screenshot-2025-03-21-at-12.17.58.png 1526w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next&#8221;
<ul>
<li><a href="https://www.benzinga.com/25/03/44439169/monster-equity-inflows-say-no-one-really-believes-trade-war-bank-of-americas-hartnett-says">&#8216;Monster Equity Inflows Say No One Really Believes Trade War,&#8217; Bank Of America&#8217;s Hartnett Says</a></li>
</ul>
Image Via Shutterstock.

Boeing Shares Are Up Today: What's Going On?

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/03/2025-03-21_08h19_48.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">Pay Attention To Sentiment</h4>
Please <a href="https://thearorareport.com/stock-market-chart-analysis-micron-earnings-fedex-sentiment-shift-mu-mc-03212025">click here</a> for a chart of Micron Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>).
Note the following:
<ul>
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of MU stock is being used to illustrate the point.</li>
<li>The chart of MU stock is important as it demonstrates the behavior of non-momo crowd investors towards tech stocks has changed, while the momo crowd is sticking to its old behavior.</li>
<li>The chart shows momo crowd buying ahead of Micron earnings.&nbsp; Since the momo crowd buys on hopium and does not take risk into account, the momo crowd buys ahead of earnings.&nbsp; In contrast, smart money tends to control risk ahead of earnings, since earnings is a risk event.</li>
<li>The chart shows the momo crowd aggressively running up MU stock after earnings to over $109.&nbsp; Micron earnings were better than the consensus and whisper numbers.</li>
<li>If the same earnings were reported at any time over the last two years, this morning MU stock would have rocketed further, perhaps to $120.&nbsp; Instead, the chart shows MU stock has fallen to $99.45 as of this writing in the premarket, not only giving up its gain but also turning negative.&nbsp;&nbsp;</li>
<li>In our analysis, non-momo crowd investors took advantage of momo crowd buying and sold into the strength.  The same pattern is being seen in many tech stocks.  </li>
<li>Micron is one of the three largest manufacturers of semiconductor memory in the world.&nbsp; Semiconductor memory has become the lifeblood of the modern economy.</li>
<li>More important is that Micron produces the most advanced high bandwidth memory.&nbsp; High bandwidth memory is essential for AI.</li>
<li>The reversal in MU stock is causing sentiment to dampen on all tech stocks.</li>
<li>We have previously shared with readers about Nvidia GTC.&nbsp; In terms of Nvidia suppliers, Micron is the biggest beneficiary of what we learned at Nvidia GTC about NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) new chips.&nbsp; Information from Nvidia GTC is negative for Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), and Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>).</li>
<li>Yesterday was Nvidia's first ever Quantum Day.  We wrote in <a href="https://www.benzinga.com/markets/equities/25/03/44421496/nvidias-first-quantum-computing-day-4-5t-quad-witching-european-banks-beat-tech-stocks-by-34">yesterday's </a>Morning Capsule:</li>
</ul>
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">In our analysis, there is a high probability of a sell-the-news reaction in quantum stocks.  Quantum computing has the potential to be bigger than the internet.
</blockquote>
<ul>
<li>The Arora Report's call about quantum computing has proven spot on.  Quantum computing stocks such as IONQ Inc (IONQ), Rigetti Computing Inc (RGTI), D-Wave Quantum Inc (QBTS), Quantum Computing Inc (QUBT), and Arqit Quantum Inc (ARQQ) have experienced major drops.</li>
<li>Adding to the pall for non-tech stocks this morning are earnings from FedEx Corp (FDX).&nbsp; FedEx is a global shipping and logistics giant.&nbsp; FedEX earnings, in big part, depend on the strength of the global economy.&nbsp; FedEx reported earnings below consensus and whisper numbers.&nbsp; FDX stock is down over 9% as of this writing in the premarket.</li>
<li>After FedEx hurting consumer discretionary stocks this morning are earnings from Nike Inc (NKE). The Nike turnaround is going to take longer under its new highly respected CEO. As full disclosure, NKE is in the Portfolio that surrounds The Arora Report&#8217;s ZYX Buy Core Model Portfolio.</li>
<li>Helping cushion in the drop in the stock market this morning is the expiration of futures this morning.&nbsp; Options will expire at the end of the day and may exert upward pressure.&nbsp; $4.5T of derivatives are expiring today.</li>
<li>In the Afternoon Capsule after the Fed announcement, we shared with you that the stock market was running up on aggressive momo crowd buying.&nbsp; At a time when the stock market was running up on aggressive buying, we wrote:</li>
</ul>
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">Powell has done a masterful job of comforting the stock market.  However, prudent investors should note that the risks are not balanced anymore and the dot plot is mildly more hawkish.  Right now, the momo crowd is buying stocks as Powell provides comfort.  Smart money is not likely to find the same comfort that the momo crowd is finding.
</blockquote>
<ul>
<li>The foregoing call has proven spot on.&nbsp; The stock market has now given up all of the Fed rally and more.</li>
<li>The stock market needs to make a stand right around here and go up.&nbsp; Otherwise, the momo crowd will incur major losses.&nbsp; In The Arora Report analysis, if the momo crowd incurs major losses, they will have less buying power to run up the stock market.&nbsp; Over the last two years, the momo crowd has been the primary force running up the stock market.&nbsp; It is important to pay attention to the momo crowd's buying power.&nbsp;&nbsp;</li>
</ul>
<h4 class="wp-block-heading">Germany</h4>
In a watershed event, for the first time since World War II, Germany approved 500B euros in infrastructure and defense spending in addition to a borrowing increase.
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are negative in Apple Inc (AAPL), Amazon.com, Inc. (AMZN), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), NVIDIA Corp (NVDA), and Tesla Inc (TSLA).
In the early trade, money flows are negative in SPDR S&amp;P 500 ETF Trust (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is range bound.
<h4 class="wp-block-heading">Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  The proprietary protection band from The Arora Report puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Market Summary

Opinion

AVGO

INTC

NVDA

High Bandwidth Memory Beneficiary Of Nvidia Chips But Micron Reverses, FedEx Hurts Sentiment

Macro Economic Events

Contracts

Politics

Economics

ORCL

SNAP

ByteDance's Existing Investors Are Front-Runners In Talks To Acquire Short Video App TikTok's U.S. Operations

Wall Street remains in the red heading into the end of the week, with major indexes posting modest midday losses in New York, though well off <a href="https://www.benzinga.com/markets">the session&#8217;s earlier lows.</a>
At a White House event, President Donald Trump said there would be flexibility on the upcoming tariffs, easing investor concerns that their planned implementation on April 2 could trigger major disruptions.
Read also: <a href="https://www.benzinga.com/25/03/44439169/monster-equity-inflows-say-no-one-really-believes-trade-war-bank-of-americas-hartnett-says">&#8216;Monster Equity Inflows Say No One Really Believes Trade War,&#8217; Bank Of America&#8217;s Hartnett Says</a>
The news helped improve risk sentiment in equities, while gold is having its worst session since late February, down 1% as traders scale back positions in safe-haven assets.
The U.S. dollar reversed course to notch weekly gains after two consecutive weeks of losses. Among mega-cap stocks, Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) led the way, climbing 4.9% and 4.2%, respectively.
Boeing, up 11% for the week, is on track for its strongest weekly performance since July 2023 after securing a multibillion-dollar contract to design and build a next-generation fighter jet for the U.S. Air Force—beating out rival Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), which fell 6%.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dipped 0.4% to below $84,000 but is still holding onto weekly gains.
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>41,851.01</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,623.24</td>
<td>-0.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,637.84</td>
<td>-0.4%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,056.35</td>
<td>-0.6%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 4:45 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.7% to $561.86.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) fell 0.4% to $418.47.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;was down 0.2% to $478.28.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.6% to $203.82</li>
<li>The&nbsp;Communication&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) outperformed, up 0.4%; the&nbsp;Materials&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>) was the worst sector performer, down 1.5%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
<ul>
<li>FedEx Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) tumbled 7.9% in reaction to quarterly earnings, eyeing the worst day since September. </li>
<li>Other stocks reacting to earnings included Carnival Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>), up 0.3%, NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), down 3%, Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), down 7.9%, Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), down 4.5%, Lennar Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>), down 4%. </li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/news/econ-s/25/03/44435609/sp-500-could-soar-12-by-year-end-but-only-if-recession-is-avoided-goldman-sachs-says">S&amp;P 500 Could Soar 12% By Year-End—But Only If Recession Is Avoided, Goldman Sachs Says</a></li>
</ul>
Photo: Shutterstock

Government

Large Cap

Regulations

Broad U.S. Equity ETFs

Econ #s

Tech

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

TSLA

Wall Street Trims Losses As Boeing Eyes Best Week In Nearly 2 Years: What's Driving Markets Friday?

<h3>Gainers</h3>
<ul>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock moved upwards by 33.5% to $1.01 during Friday's regular session. The company's market cap stands at $20.7 million. </li>
<li>Ouster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NASDAQ">OUST</a>) stock increased by 26.19% to $10.58. The market value of their outstanding shares is at $547.4 million. The company's, Q4 earnings came out yesterday. </li>
<li>AuthID (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUID#NASDAQ">AUID</a>) shares rose 18.78% to $7.46. The market value of their outstanding shares is at $81.4 million. </li>
<li>PicoCELA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCLA#NASDAQ">PCLA</a>) shares rose 12.91% to $0.95. The market value of their outstanding shares is at $29.3 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock rose 11.24% to $0.62. </li>
<li>Alarum Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) stock moved upwards by 11.19% to $7.35. The company's market cap stands at $50.9 million. As per the press release, Q4 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Exodus Movement (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EXOD#AMEX">EXOD</a>) shares declined by 18.6% to $39.5 during Friday's regular session. The company's market cap stands at $1.1 billion. </li>
<li>Bit Origin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) stock declined by 11.6% to $0.26. The company's market cap stands at $2.2 million. </li>
<li>ScanTech AI Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAI#NASDAQ">STAI</a>) stock fell 11.12% to $2.56. The company's market cap stands at $53.0 million. </li>
<li>TROOPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) stock declined by 8.69% to $0.76. The market value of their outstanding shares is at $77.6 million. </li>
<li>Tungray Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) stock declined by 8.44% to $1.14. The company's market cap stands at $18.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AUID

BTOG

EXOD

OUST

PCLA

SOBR

STAI

TROO

TRSG

11 Information Technology Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) shares increased by 49.1% to $3.4 during Friday's regular session. The company's market cap stands at $20.2 million. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) stock moved upwards by 17.29% to $1.56. The market value of their outstanding shares is at $53.8 million. </li>
<li>Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) stock moved upwards by 17.19% to $7.36. The company's market cap stands at $245.0 million. The company's, Q4 earnings came out yesterday. </li>
<li>Inspirato (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) shares rose 11.63% to $4.51. The market value of their outstanding shares is at $48.7 million. </li>
<li>a.k.a. Brands Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) stock increased by 10.98% to $13.62. The market value of their outstanding shares is at $145.6 million. </li>
<li>Nxu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXU#NASDAQ">NXU</a>) shares increased by 9.49% to $0.28. The company's market cap stands at $6.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) shares declined by 69.7% to $0.04 during Friday's regular session. The market value of their outstanding shares is at $1.1 million. </li>
<li>Aureus Greenway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGH#NASDAQ">AGH</a>) shares fell 30.0% to $0.74. The company's market cap stands at $10.2 million. </li>
<li>SAG Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAG#NASDAQ">SAG</a>) shares declined by 24.36% to $0.88. The market value of their outstanding shares is at $8.7 million. </li>
<li>KinderCare Learning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLC#NYSE">KLC</a>) stock decreased by 20.41% to $14.07. The company's market cap stands at $1.6 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock declined by 15.12% to $5.56. The company's market cap stands at $21.5 million. </li>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) shares decreased by 14.56% to $0.41. The company's market cap stands at $3.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALUR

GDHG

ISPO

LAZR

RENT

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) stock increased by 98.1% to $4.12 during Friday's regular session. The company's market cap stands at $47.4 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock moved upwards by 60.9% to $1.24. </li>
<li>Galecto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLTO#NASDAQ">GLTO</a>) shares increased by 40.09% to $5.8. The market value of their outstanding shares is at $7.6 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) stock increased by 30.36% to $58.67. The market value of their outstanding shares is at $763.4 million. </li>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) stock moved upwards by 26.71% to $23.05. The company's market cap stands at $128.8 million. As per the news, the Q4 earnings report came out 3 days ago. </li>
<li>CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) shares moved upwards by 21.49% to $14.04. The market value of their outstanding shares is at $115.9 million. As per the press release, Q4 earnings came out 4 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TC BioPharm (Holdings) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) stock fell 62.1% to $0.58 during Friday's regular session. The company's market cap stands at $5.9 million. </li>
<li>TELA Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELA#NASDAQ">TELA</a>) shares decreased by 38.47% to $1.44. The market value of their outstanding shares is at $56.7 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) shares declined by 31.95% to $0.28. The market value of their outstanding shares is at $2.9 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) stock declined by 23.4% to $1.67. The market value of their outstanding shares is at $1.2 million. </li>
<li>Monopar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNPR#NASDAQ">MNPR</a>) shares decreased by 16.92% to $37.17. The company's market cap stands at $226.8 million. </li>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) shares fell 14.53% to $0.22. The company's market cap stands at $1.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRVO

GCTK

GLTO

MNPR

RNAZ

STSS

TCBP

TNXP

WINT

12 Health Care Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>HUHUTECH International Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUHU#NASDAQ">HUHU</a>) shares rose 35.4% to $6.42 during Friday's regular session. The company's market cap stands at $135.9 million. </li>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares moved upwards by 27.8% to $2.62. The market value of their outstanding shares is at $39.0 million. </li>
<li>Flux Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>) stock moved upwards by 20.61% to $1.96. The market value of their outstanding shares is at $32.6 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Amprius Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) shares moved upwards by 20.12% to $2.77. The market value of their outstanding shares is at $306.8 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) shares rose 18.96% to $17.38. The company's market cap stands at $77.9 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>SUNation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNE#NASDAQ">SUNE</a>) stock increased by 13.69% to $0.51. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MingZhu Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) stock fell 13.1% to $0.82 during Friday's regular session. The market value of their outstanding shares is at $62.6 million. </li>
<li>INLIF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INLF#NASDAQ">INLF</a>) stock decreased by 12.66% to $2.0. The company's market cap stands at $29.0 million. </li>
<li>VCI Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) stock declined by 11.81% to $0.73. The company's market cap stands at $26.3 million. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) shares declined by 11.73% to $1.2. The market value of their outstanding shares is at $13.2 million. </li>
<li>Icon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) stock decreased by 11.52% to $0.09. The market value of their outstanding shares is at $2.5 million. </li>
<li>Valmont Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) stock fell 10.94% to $290.86. The market value of their outstanding shares is at $5.8 billion. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMPX

CLIK

FLUX

HKPD

HUHU

ICON

INLF

SUNE

TISI

VCIG

YGMZ

12 Industrials Stocks Moving In Friday's Intraday Session

Press Releases

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals' $6 Million Follow-On Offering

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference

Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

Stocks Under $1: PMAX PRSO ARBB KAVL to Watch in March 2025 – More Stocks Inside

Virpax's NES100 to be Presented at The Society of Toxicology by NCATS

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND

Virpax Pharmaceuticals Announces Reverse Stock Split

ADTX

AIBT

ARBB

CSDX

KAVL

PMAX

PRSO

SIGL

TSXV:YGT

YGTFF

ALT5 Sigma

Alto Neuroscience

AN2 Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Assertio Holdings

CalciMedica

Context Therapeutics

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Durect

Grace Therapeutics

Ikena Oncology

Opus Genetics

Iterum Therapeutics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lexaria Bioscience

NRX Pharmaceuticals

Pulmatrix

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

Scilex Holding

SCYNEXIS

Veru

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals

米国の小売業者ファイブ・ビロウ(Five Below）（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>）の株は、市場予想を上回る四半期決算を発表し、第1四半期の<a href="https://in.benzinga.com/news/earnings/25/03/44406668/five-below-stock-moves-higher-on-q4-earnings-beat">見通し予想</a>を上回ることを受け、市場取引開始前の取引で株価が急上昇した。
ファイブ・ビロウは1株あたり3.48ドルの修正利益を報告した。これは市場予想（1株あたり3.38ドル）を上回っている。同社の売上は13億9100万ドルに対し、市場予想は13億8600万ドルだった。
ファイブ・ビロウの株は、プレマーケット取引で11.9％上昇して84.59ドルに急騰した。
以下は、プレマーケット取引で変動率が大きい銘柄である。
<h3 class="wp-block-heading">上昇銘柄</h3>
<ul>
<li>SAGホールディングス(SAG Holdings Limited)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAG#NASDAQ">SAG</a>）の株は、水曜日に7％上昇した後、プレマーケット取引で77.8％増の1.20ドルに急騰。</li>
<li>オプティノーズ(OptiNose, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTN#NASDAQ">OPTN</a>）の株は、プレマーケット取引で59.3％上昇の9.56ドルに上昇。パラテック・ファーマシューティカルズ(Paratek Pharmaceuticals)は、最大3.3億ドルでオプティノーズを買収する計画を発表。</li>
<li>プロアシュアランス(ProAssurance Corporation)（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>）の株は、1株25.00ドルの現金で株式を買い取ることを発表した後、プレマーケット取引で50.6％急騰の23.41ドルに上昇。</li>
<li>AGMグループホールディングス(AGM Group Holdings Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>）は、プレマーケットで0.1010ドル（約11.1円）に40.3％上昇。AGMグループホールディングスは、米国証券取引所（ナスダック）から最低入札要件に関する通知を受け取ったと発表。</li>
<li>DevvStream Corp（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DEVS#NASDAQ">DEVS</a>）の株は、水曜日に8％上昇した後、プレマーケット取引で28.7％上昇の0.4761ドルに急騰。</li>
<li>エマーソン・ラジオ(Emerson Radio Corp)（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSN#NYSE">MSN</a>）は、プレマーケット取引で27.2％上昇の0.56ドル。</li>
<li>CIMG Inc（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMG#NYSE">IMG</a>）の株は、同社の子会社がShanghai Huomaoとビジネス協力意向書に署名したと発表したことを受け、プレマーケット取引で21.1％上昇の0.5812ドルに急騰。</li>
<li>IOバイオテック(IO Biotech, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>）の株は、プレマーケット取引で12.1％上昇の1.02ドルに上昇。</li>
<li>ブルックデール・シニア・リビング（Brookdale Senior Living Inc)（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKD#NYSE">BKD</a>）の株は、プレマーケット取引で8.1％上昇の6.60ドルに上昇。</li>
</ul>
<h3 class="wp-block-heading">下落銘柄</h3>
<ul>
<li>ズームカー・ホールディングス(Zoomcar Holdings, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>）の株は、逆株式分割1対20を発表した後、プレマーケット取引で28.4％急落の0.2196ドル。</li>
<li>アケビア・セラピューティクス(Akebia Therapeutics, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>）の株は、1株当たり2ドルで公開株式の2,500万株を5000万ドルで売却すると発表した後、プレマーケット取引で26.2％下落の2.09ドル。</li>
<li>レイシェン・エナジー・ホールディング（Leishen Energy Holding Co., Ltd）（NYSE:<a class="ticker" style="font-weight: revert;" href="https://www.benzinga.com/stock/LSE#NYSE">LSE</a>）の株は、水曜日に約66％上昇した後、プレマーケット取引で17.1％下落の10.37ドルに急落。最近、2024年度の業績報告を発表したばかり。</li>
<li>リバービュー・バンコープ(Riverview Bancorp, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVSB#NASDAQ">RVSB</a>）の株は、プレマーケット取引で13.2％急落の4.66ドル。</li>
<li>ベンソン・ヒル(Benson Hill, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHIL#NASDAQ">BHIL</a>）は、水曜日に15％下落した後、プレマーケット取引で13.2％急落の0.56ドルに下落。</li>
<li>バーパックス・ファーマシューティカルズ(Virpax Pharmaceuticals, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>）の株は、逆株式分割1対25を発表した後、プレマーケット取引で13.2％急落の0.0944ドル。同社が逆株式分割を発表した水曜日に16％下落。</li>
<li>メイホワ・インタナショナル・メディカル・テクノロジズ（Meihua International Medical Technologies Co., Ltd）（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHUA#NASDAQ">MHUA</a>）の株は、プレマーケット取引で12.3％下落の0.2884ドル。</li>
<li>本日のプレマーケット取引でMaze Therapeutics, Inc（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAZE#NASDAQ">MAZE</a>）の株は11.8％下落し、10.70ドル。</li>
<li>ジョイ(JOYY Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YY#NASDAQ">YY</a>）の株は、今日のプレマーケット取引で10.8％下落の41.78ドル。同社の四半期決算が弱かったことを受けての下落。</li>
<li>エナーフレックス(Enerflex Ltd)（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFXT#NYSE">EFXT</a>）の株は、代表、CEO、取締役でもあるマーク・ロシター氏の辞任発表により、プレマーケット取引で7.1％下落の7.00ドル。</li>
</ul>
次の記事を読む：
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44396642/jim-cramer-says-tjx-is-terrific-recommends-buying-these-stocks">Jim Cramer氏はTJXが「素晴らしい」と述べ、これらの銘柄の購入をお勧め</a></li>
</ul>

Comments

Virpax Pharmaceuticals

ニュース

最新ニュース Virpax Pharmaceuticals (NASDAQ:VRPX) 株価情報

木曜日, 3 20, 2025

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル